Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by jwalliscaon Nov 20, 2019 7:05pm

126 Views

Post# 30376099

Redbaron2211: Tuck-ins, or Tuck-away ;)

An excerpt from the news release via Rb2211's link says it all, which was paraphrased by elgin1. See below.

For Medtronic, U$1 - U$2 billion becomes a "tuck-in" rounding error on the worth of Medtronic and its total financials. We must remember the Vertex Vortex of SEMMA was U$955 million on something far back in development compared with The Pouch. Then there was Sanofi that took out Bioverativ for the Hemophilia only at some U$11.6 billion...

The Pouch will do Diabetes, Hemophilia, Thyroid AND very likely more human ailments like Parkinson's. I don't see C$2 billion (U$1.5 billion) as a problem for a Big Pharma to Tuck-it-in-to bed... for a couple of billion beaver bucks.

I am working on some hypotheses in the absence of news to keep us all "SHARP" on this BB..

One is that an entity will do a Buy, Bye once data (presumably Tom T Terrific) from at least two more Pouches are available, i.e. confirmation. Since Sernova had full coin middle of September (and some coin a month earlier), this suggests late November to mid-December to reach the 90 day point on the new pouches. A possible Christmas present??

We shall see of course, but it is a logical surmise...

Cheers,

jwall

...getting more aggressive with tuck-in M&A and being decisive with capital allocation to the highest growth segments,” Geoff Martha said on a post-earnings conference call.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?